Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Schoffer

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Plos One|December 5, 2019
Ranking hospitals when performance and risk factors are correlated: A simulation-based comparison of risk adjustment approaches for binary outcomesMartin Roessler, Jochen Schmitt, Olaf Schoffer
Plos One|September 7, 2021
Can we trust the standardized mortality ratio? A formal analysis and evaluation based on axiomatic requirementsMartin Roessler, Jochen Schmitt, Olaf Schoffer
Deutsches Arzteblatt International|September 21, 2023
Positive Effect on Prognostic FactorsThomas Datzmann, Jochen Schmitt, Olaf Schoffer
Deutsches Arzteblatt International|April 26, 2024
In ReplyJochen Schmitt, Olaf Schoffer, Monika Klinkhammer-Schalke
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 26, 2023
Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival AnalysisVeronika Bierbaum, Jochen Schmitt, Monika Klinkhammer-Schalke, et al.
Cancers|August 23, 2020
Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016Peter Hellmund, Jochen Schmitt, Martin Roessler, et al.
Cancers|December 24, 2021
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010-2020-Cohort Study Based on Administrative DataThomas Datzmann, Jochen Schmitt, Saskia Fuhrmann, et al.
Health and Quality of Life Outcomes|October 25, 2014
Health-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten SwedenAnne Neumann, Olaf Schoffer, Fredrik Norström, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 4, 2016
The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention programAnne Neumann, Lars Lindholm, Margareta Norberg, et al.
BMC Cancer|October 17, 2025
Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot studyLea Pöschmann, Friedegund Meier, Martin Eichler, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Plos One|December 5, 2019
Ranking hospitals when performance and risk factors are correlated: A simulation-based comparison of risk adjustment approaches for binary outcomesMartin Roessler, Jochen Schmitt, Olaf Schoffer
Plos One|September 7, 2021
Can we trust the standardized mortality ratio? A formal analysis and evaluation based on axiomatic requirementsMartin Roessler, Jochen Schmitt, Olaf Schoffer
Deutsches Arzteblatt International|September 21, 2023
Positive Effect on Prognostic FactorsThomas Datzmann, Jochen Schmitt, Olaf Schoffer
Deutsches Arzteblatt International|April 26, 2024
In ReplyJochen Schmitt, Olaf Schoffer, Monika Klinkhammer-Schalke
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 26, 2023
Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival AnalysisVeronika Bierbaum, Jochen Schmitt, Monika Klinkhammer-Schalke, et al.
Cancers|August 23, 2020
Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016Peter Hellmund, Jochen Schmitt, Martin Roessler, et al.
Cancers|December 24, 2021
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010-2020-Cohort Study Based on Administrative DataThomas Datzmann, Jochen Schmitt, Saskia Fuhrmann, et al.
Health and Quality of Life Outcomes|October 25, 2014
Health-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten SwedenAnne Neumann, Olaf Schoffer, Fredrik Norström, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 4, 2016
The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention programAnne Neumann, Lars Lindholm, Margareta Norberg, et al.
BMC Cancer|October 17, 2025
Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot studyLea Pöschmann, Friedegund Meier, Martin Eichler, et al.
Pageof 7